Cochlear Limited (ASX:COH – Get Free Report) insider Christine McLoughlin purchased 200 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were purchased at an average price of A$261.73 ($165.65) per share, for a total transaction of A$52,346.00 ($33,130.38).
Cochlear Stock Performance
The company has a current ratio of 2.30, a quick ratio of 1.93 and a debt-to-equity ratio of 13.24. The company has a market capitalization of $19.88 billion, a P/E ratio of 55.90, a PEG ratio of 3.87 and a beta of 0.47.
Cochlear Increases Dividend
The company also recently announced a Interim dividend, which will be paid on Sunday, April 13th. Stockholders of record on Sunday, April 13th will be paid a $2.15 dividend. The ex-dividend date is Wednesday, March 19th. This represents a dividend yield of 0.78%. This is a boost from Cochlear’s previous Interim dividend of $2.00. Cochlear’s payout ratio is 77.35%.
Cochlear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
- Five stocks we like better than Cochlear
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Buy P&G Now, Before It Sets A New All-Time High
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How to find penny stocks to invest and trade
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
